The 16th Royal Marsden Head and Neck Conference centres on neoadjuvant and adjuvant immunotherapy in the surgical management of head and neck carcinoma. The official page says the meeting will examine the evidence, practical experience and pitfalls as trial findings move into contemporary care. Its scope spans diagnostics, surgical and oncological management, rehabilitation, follow-up and technological advances, with attention to ongoing research likely to change practice. The invitation extends to medical and nursing staff, allied health professionals and multidisciplinary-team members working across primary, secondary and tertiary care, making it relevant to ENT, maxillofacial, oncology and related trainees. No abstract-submission route, attendee presentation format or publication outcome is stated on the conference page, programme link or Tito booking page. Registration is £200 for a full delegate and £150 for trainees and clinical nurse specialists; no student price, early-bird rate or closing date is published. The conference runs from 09:00 to 17:00 at the Royal Marsden Education and Conference Centre in Chelsea. A programme PDF and a discounted Strathmore Hotel rate using code C00006BF are linked from the official page.